208 related articles for article (PubMed ID: 32409195)
1. Exploring the Impact of Lung Cancer Screening on Lung Cancer Mortality of Smokers With Obstructive Lung Disease: Analysis of the NLST-ACRIN Cohort.
de-Torres JP; Wisnivesky JP; Bastarrika G; Wilson DO; Celli BR; Zulueta JJ
Arch Bronconeumol (Engl Ed); 2021 Jan; 57(1):36-41. PubMed ID: 32409195
[TBL] [Abstract][Full Text] [Related]
2. Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality.
Prosper AE; Inoue K; Brown K; Bui AAT; Aberle D; Hsu W
JAMA Netw Open; 2021 Aug; 4(8):e2119629. PubMed ID: 34427681
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP).
Sanchez-Salcedo P; Berto J; de-Torres JP; Campo A; Alcaide AB; Bastarrika G; Pueyo JC; Villanueva A; Echeveste JI; Lozano MD; García-Velloso MJ; Seijo LM; García J; Torre W; Pajares MJ; Pío R; Montuenga LM; Zulueta JJ
Arch Bronconeumol; 2015 Apr; 51(4):169-76. PubMed ID: 25641356
[TBL] [Abstract][Full Text] [Related]
4. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Jonas DE; Reuland DS; Reddy SM; Nagle M; Clark SD; Weber RP; Enyioha C; Malo TL; Brenner AT; Armstrong C; Coker-Schwimmer M; Middleton JC; Voisin C; Harris RP
JAMA; 2021 Mar; 325(10):971-987. PubMed ID: 33687468
[TBL] [Abstract][Full Text] [Related]
5. Performance of the cancer risk management model lung cancer screening module.
Flanagan WM; Evans WK; Fitzgerald NR; Goffin JR; Miller AB; Wolfson MC
Health Rep; 2015 May; 26(5):11-8. PubMed ID: 25993046
[TBL] [Abstract][Full Text] [Related]
6. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment.
Pinsky PF; Gierada DS; Black W; Munden R; Nath H; Aberle D; Kazerooni E
Ann Intern Med; 2015 Apr; 162(7):485-91. PubMed ID: 25664444
[TBL] [Abstract][Full Text] [Related]
7. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial.
National Lung Screening Trial Research Team
J Thorac Oncol; 2019 Oct; 14(10):1732-1742. PubMed ID: 31260833
[TBL] [Abstract][Full Text] [Related]
8. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy.
Pastorino U; Silva M; Sestini S; Sabia F; Boeri M; Cantarutti A; Sverzellati N; Sozzi G; Corrao G; Marchianò A
Ann Oncol; 2019 Jul; 30(7):1162-1169. PubMed ID: 30937431
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Follow-up Results of the DANTE Trial, a Randomized Study of Lung Cancer Screening with Spiral Computed Tomography.
Infante M; Cavuto S; Lutman FR; Passera E; Chiarenza M; Chiesa G; Brambilla G; Angeli E; Aranzulla G; Chiti A; Scorsetti M; Navarria P; Cavina R; Ciccarelli M; Roncalli M; Destro A; Bottoni E; Voulaz E; Errico V; Ferraroli G; Finocchiaro G; Toschi L; Santoro A; Alloisio M;
Am J Respir Crit Care Med; 2015 May; 191(10):1166-75. PubMed ID: 25760561
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
[TBL] [Abstract][Full Text] [Related]
11. Overwhelming support among urban Irish COPD patients for lung cancer screening by low-dose CT scan.
Pallin M; Walsh S; O'Driscoll MF; Murray C; Cahalane A; Brown L; Carter M; Mitchell P; McDonnell TJ; Butler MW
Lung; 2012 Dec; 190(6):621-8. PubMed ID: 23064487
[TBL] [Abstract][Full Text] [Related]
12. Impact of Low-Dose Computed Tomography Screening for Primary Lung Cancer on Subsequent Risk of Brain Metastasis.
Su CC; Wu JT; Neal JW; Popat RA; Kurian AW; Backhus LM; Nagpal S; Leung AN; Wakelee HA; Han SS
J Thorac Oncol; 2021 Sep; 16(9):1479-1489. PubMed ID: 34091050
[TBL] [Abstract][Full Text] [Related]
13. Ten-year results of the Multicentric Italian Lung Detection trial demonstrate the safety and efficacy of biennial lung cancer screening.
Pastorino U; Sverzellati N; Sestini S; Silva M; Sabia F; Boeri M; Cantarutti A; Sozzi G; Corrao G; Marchianò A
Eur J Cancer; 2019 Sep; 118():142-148. PubMed ID: 31336289
[TBL] [Abstract][Full Text] [Related]
14. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial.
Tanner NT; Kanodra NM; Gebregziabher M; Payne E; Halbert CH; Warren GW; Egede LE; Silvestri GA
Am J Respir Crit Care Med; 2016 Mar; 193(5):534-41. PubMed ID: 26502000
[TBL] [Abstract][Full Text] [Related]
15. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial.
Becker N; Motsch E; Trotter A; Heussel CP; Dienemann H; Schnabel PA; Kauczor HU; Maldonado SG; Miller AB; Kaaks R; Delorme S
Int J Cancer; 2020 Mar; 146(6):1503-1513. PubMed ID: 31162856
[TBL] [Abstract][Full Text] [Related]
16. Low positive predictive value of computed tomography screening for lung cancer irrespective of commonly employed definitions of target population.
Krilaviciute A; Brenner H
Int J Cancer; 2021 Jul; 149(1):58-65. PubMed ID: 33634860
[TBL] [Abstract][Full Text] [Related]
17. Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation.
Tanner NT; Gebregziabher M; Hughes Halbert C; Payne E; Egede LE; Silvestri GA
Am J Respir Crit Care Med; 2015 Jul; 192(2):200-8. PubMed ID: 25928649
[TBL] [Abstract][Full Text] [Related]
18. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
[TBL] [Abstract][Full Text] [Related]
19. Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation.
Snowsill T; Yang H; Griffin E; Long L; Varley-Campbell J; Coelho H; Robinson S; Hyde C
Health Technol Assess; 2018 Nov; 22(69):1-276. PubMed ID: 30518460
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]